Nesta página
CELZ Creative Medical Technology Holdings, Inc. - Common Stock
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 7, 2026
$0,95
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$0,62mínima 52 sem
$6,25máxima 52 sem
Capitalização de Mercado (MRQ)
$6M
P/E (TTM)
-0.3
EPS (TTM)
$-3.66
Receita (TTM)
$3.0K
seus distintivos
Intervalo 52 Semanas
$1–$6
Classificação do Analista
BUY
Preço-Alvo
$20
P/E
-0.3
ROE
-78.0%
Margem de Lucro Líquido
-201355.4%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
CELZ Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.95
Capitalização de Mercado (MRQ)
$6M
P/E (TTM)
-0.3
EPS (TTM)
$-3.66
Receita (TTM)
$3.0K
ROE (TTM)
-78.0%
Intervalo 52 Semanas
$1–$6
CELZ Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 12 de Junho de 2023 | 1-for-10 | Reverso |
| 10 de Novembro de 2021 | 1-for-500 | Reverso |
| 3 de Fevereiro de 2020 | 1-for-150 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$6.0K2016-12-31 → 2025-12-31
EPS$-2.522020-12-31 → 2025-12-31
Margem líquida-201355.4%2017-12-31 → 2020-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | CELZ | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -0.3média 5A ≈-0.6 | ≈-0.6 | · | · | |
| P/S (TTM) | 2048.0 | · | 1.8 | Sobreavaliado | |
| P/B (MRQ) | 0.7 | · | 0.8 | Sobreavaliado | |
| Preço / Valor Patrimonial Tangível (MRQ) | 0.7média 5A ≈4.1 | ≈4.1 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | CELZ | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 66.9% | · | · | · | |
| Margem Operacional (TTM) | -208004.4% | · | · | · | |
| Margem de Impostos Pré-Tributação (TTM) | -201285.8% | · | · | · | |
| Margem de Lucro Líquido (TTM) | -201355.4% | · | · | · | |
| ROA (TTM) | -73.3% | · | -62.7% | Fraco | |
| ROE (TTM) | -78.0% | · | -92.9% | Em linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | CELZ | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 12.9 | · | 2.8 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | CELZ | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -45.5%média 5A ≈-31.8% | ≈-31.8% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -59.2%média 5A ≈-57.1% | ≈-57.1% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | -48.4% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | CELZ | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$1.5K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-27.9%
Próximo relatório
Nov 05, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 6, 2026 | $-0.41 | $-0.40 | -3.1% |
| 31 de Março de 2026 | Mai 7, 2026 | $-0.38 | $-0.40 | 4.5% |
| 31 de Dezembro de 2025 | $-0.73 | $-0.38 | -93.4% | |
| 30 de Setembro de 2025 | $-0.48 | $-0.49 | 2.0% | |
| 30 de Junho de 2025 | $-0.48 | $-0.64 | 25.3% | |
| 31 de Março de 2025 | $-0.83 | $-0.53 | -56.5% | |
| 31 de Dezembro de 2024 | $-1.12 | $-0.64 | -74.3% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Cost of Revenue | $2.2K | $4.4K | $3.6K | $28.5K | $47.9K | $50.6K | $45.5K | $70.4K | $8.0K | $0 | · | · | |
| Gross Profit | $3.8K | $6.6K | $5.4K | $60.1K | $39.8K | $113.9K | $120.0K | $54.0K | $-3.2K | $0 | · | · | |
| R&D Expense | $2M | $2M | $2M | $6M | $109.2K | $0 | $0 | $96.6K | $260.1K | $85.3K | · | · | |
| SG&A Expense | $4M | $3M | $4M | $4M | $3M | $1M | $1M | $1M | $898.5K | $665.0K | · | · | |
| Operating Expenses | $6M | $6M | $6M | $10M | $3M | $1M | $1M | $1M | $1M | $759.7K | $20.8K | $19.4K | |
| Operating Income | $-6M | $-6M | $-6M | $-10M | $-3M | $-1M | $-1M | $-1M | $-1M | $-759.7K | $-20.8K | $-19.4K | |
| Interest Expense | · | · | · | $0 | $4M | $1M | $2M | $1M | $377.6K | $6.4K | · | · | |
| Other Non-op | $147.8K | $250.4K | $333.6K | $100.3K | $22M | $-35M | $-7M | $-13M | $-1M | $-6.4K | · | · | |
| Pretax Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| EPS (Basic) | · | · | · | $-0.93 | $7.37 | $-62.69 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 | $-62.69 | · | · | · | · | · | · | |
| Shares (Basic) | · | · | · | 10,932,035 | 2,605,057 | 579,461 | · | · | · | · | 18,113,750 | 18,113,750 | |
| Shares (Diluted) | 2,382,797 | 1,480,420 | 1,407,632 | 10,932,035 | 3,248,619 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | · | $-1M | $-1M | · | $-1M | $-766.1K | $-20.8K | $-19.4K |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $3M | $8M | $11M | $98.0K | $88.6K | $304.1K | $13.7K | $221.9K | $100 | $954 | |
| Receivables | · | · | · | $0 | $2.5K | $0 | $5.6K | $9.6K | $4.8K | $0 | · | · | |
| Inventory | $0 | $2.2K | $6.6K | $10.2K | $10.9K | $0 | $0 | · | · | · | · | · | |
| Prepaid Expense | $138.8K | $192.7K | $277.2K | $338.1K | $0 | · | · | · | · | · | · | · | |
| Current Assets | $7M | $6M | $10M | $19M | $11M | $98.0K | $94.2K | $313.7K | $18.5K | $221.9K | $49.6K | $954 | |
| Intangibles | $407.2K | $530.6K | $441.0K | $435.6K | $527.7K | $619.8K | $436.6K | $163.5K | $184.6K | $100.6K | $0 | · | |
| Other Non-current Assets | · | · | · | · | $3.3K | · | · | · | · | · | · | · | |
| Total Assets | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Accounts Payable | $270.7K | $273.5K | $317.3K | $3M | $761.9K | $350.9K | $320.8K | $331.8K | $237.6K | $66.4K | $0 | $10.2K | |
| Accrued Liabilities | $0 | $39.9K | $39.9K | $39.9K | $24.4K | $159.8K | $120.5K | $21.6K | $23.1K | $4.9K | $0 | · | |
| Short-term Debt | · | · | · | · | · | $0 | · | · | · | · | $0 | · | |
| Current Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $453.9K | $100 | $154.0K | |
| Total Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $480.3K | $100 | $154.0K | |
| Long-term Debt | · | · | · | · | · | · | · | · | $493.2K | · | · | · | |
| Common Stock | $3.1K | $1.7K | $1.4K | $1.4K | $6.3K | $1.5K | $22.5K | $6.0K | $114.8K | $105.0K | $32.0K | $18.1K | |
| Paid-in Capital | $78M | $71M | $70M | $70M | $54M | $22M | $17M | · | · | · | $154.2K | $154.2K | |
| Retained Earnings | $-71M | $-65M | $-59M | $-54M | $-44M | $-62M | $-26M | $-17M | $-3M | $-766.6K | $-500 | $-325.3K | |
| Treasury Stock | $10.0K | $0 | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $8M | $6M | $10M | $16M | $10M | $-40M | $-8M | $-4M | $-2M | $-157.8K | $49.5K | $-153.0K | |
| Liabilities + Equity | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Shares Outstanding | 3,696,668 | 1,748,428 | 1,373,626 | 1,407,624 | 6,338,864 | 1,537,074 | 22,489,046 | 6,018,075 | 114,799,226 | 105,013,750 | 32,010,000 | 18,113,750 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $56.0K | $56.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $3.5K | $36.6K | $36.6K | $68.7K | $595.4K | $170.3K | $0 | $1.9K | $144.2K | $2.6K | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Amort. of Intangibles | $123.3K | $110.5K | $94.6K | $92.1K | $92.1K | $66.8K | $26.9K | $21.1K | $16.0K | $9.4K | · | · | |
| Operating Cash Flow | $-6M | $-5M | $-8M | $-8M | $-2M | $-434.6K | $-1M | $-1M | $-889.6K | $-445.2K | $-14.6K | $-17.3K | |
| Investing Cash Flow | $-50.5K | $6M | $3M | $-10M | $0 | $-250.0K | $0 | · | $0 | $-10.0K | $0 | $0 | |
| Stock Issued | $7M | $2M | $0 | $15M | $15M | $0 | · | $0 | $100.0K | $500.0K | · | · | |
| Stock Repurchased | $10.0K | $175.0K | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $100.0K | $500.0K | · | · | |
| Financing Cash Flow | $7M | $1M | $-271.0K | $15M | $13M | $693.9K | $997.7K | $1M | $681.5K | $677.0K | $13.9K | $17.9K | |
| Net Change in Cash | $1M | $2M | · | · | · | $9.4K | $-215.4K | $290.4K | $-208.2K | $221.8K | $-738 | $580 | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 69.2% | 72.5% | · | -66.7% | · | · | · | |
| Operating Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| Net Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | -55398.1% | · | · | · | |
| Pretax Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| ROA | · | · | · | · | · | -5818.7% | -1683.3% | · | -1011.7% | -411.7% | -5258.3% | -4218.7% | |
| ROE | · | · | · | · | · | 170.6% | 145.8% | · | 222.1% | 1414.8% | 33.5% | 20.2% | |
| ROIC | · | · | · | · | · | 2.8% | 14.0% | · | · | · | · | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Quick Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | -0.9 | -0.6 | · | -3.1 | · | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.3 | 0.3 | · | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 58.8 | 21.8 | · | 2.0 | · | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | $-0.05 | $-0.36 | · | $-0.02 | $-0.00 | $-0.01 | $-0.01 | |
| Cash / Share | · | · | · | · | · | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 | $-62.69 | · | · | · | · | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -45.5% | 22.2% | -89.8% | 0.96% | -46.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -59.2% | -50.0% | -62.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -48.4% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Net Income TTM | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| Market Cap | · | · | · | · | · | $106.83B | $5.06B | · | $1.16T | $40.17T | $149.44B | · | |
| P/E | -0.8 | -0.6 | -1.2 | -4.1 | 3.9 | -2.2 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | 649401.8 | 30574.2 | · | 242154617.3 | · | · | · | |
| P/B | · | · | · | · | · | -2683.9 | -626.9 | · | -519790.8 | -254563057.3 | -813031.5 | · | |
| P / Tangible Book | 1.0 | 0.7 | 0.6 | 3.5 | 14.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | -245829.3 | -4171.2 | · | -1306558.8 | 90217593.0 | -10208938.2 | · | |
| Earnings Yield | -128.6% | -160.6% | -81.6% | -24.4% | 25.4% | -45.1% | · | · | · | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $3.0K | $0 | $0 | $3.0K | $3.0K | $0 | $8.0K | $0 | $3.0K | $6.0K | $0 | $0 | $18.6K | $55.0K | |
| Cost of Revenue | $0 | $0 | $994 | $0 | $0 | $1.2K | $1.2K | $0 | $3.2K | $0 | $1.2K | $2.4K | $0 | $0 | $5.7K | $16.0K | |
| Gross Profit | $0 | $0 | $2.0K | $0 | $0 | $1.8K | $1.8K | $0 | $4.8K | $0 | $1.8K | $3.6K | $0 | $0 | $12.9K | $39.0K | |
| R&D Expense | $459.2K | $541.7K | $550.1K | $465.2K | $501.3K | $743.3K | $471.8K | $581.8K | $924.7K | $422.4K | $349.4K | $992.7K | $309.5K | $319.0K | $5M | $230.9K | |
| SG&A Expense | $1M | $888.6K | $1M | $776.8K | $731.5K | $888.4K | $1M | $498.6K | $676.1K | $671.5K | $1M | $531.0K | $859.5K | $771.0K | $899.6K | $805.5K | |
| Operating Expenses | $2M | $1M | $2M | $1M | $1M | $2M | $2M | $1M | $2M | $1M | $2M | $2M | $1M | $1M | $6M | $1M | |
| Operating Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-2M | $-1M | $-1M | $-6M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $50 | · | $0 | |
| Other Non-op | $50.9K | $55.4K | $58.1K | $37.1K | $30.2K | $22.4K | $31.7K | $69.5K | $67.6K | $81.6K | $93.3K | $89.2K | $89.9K | $61.1K | $62.2K | $38.1K | |
| Pretax Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.07 | |
| EPS (Diluted) | $-0.41 | $-0.38 | $-2.39 | $-0.48 | $-0.48 | $-0.83 | $-2.58 | $-0.75 | $-1.11 | $0.73 | · | · | · | · | · | $-0.07 | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 14,068,412 | |
| Shares (Diluted) | 3,701,668 | 3,701,668 | · | 2,580,532 | 2,580,532 | 1,980,735 | · | 1,392,284 | 1,405,208 | 1,421,439 | · | · | · | · | · | 14,068,412 | |
| EBITDA | $-2M | $-1M | · | $-1M | $-1M | $-2M | · | $-1M | $-2M | $-1M | · | $-2M | $-1M | $-1M | · | $-1M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | $5M | $4M | $10M | $8M | $17M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Inventory | $125.0K | $125.0K | $0 | $994 | $994 | $994 | $2.2K | $3.4K | $3.4K | $6.6K | $6.6K | $7.8K | $10.2K | $10.2K | $10.2K | $15.9K | |
| Prepaid Expense | $70.5K | $105.0K | $138.8K | $35.0K | $87.6K | $140.2K | $192.7K | $67.6K | $129.1K | $190.6K | $277.2K | $61.5K | $153.7K | $245.9K | $338.1K | · | |
| Current Assets | $9M | $6M | $7M | $5M | $7M | $8M | $6M | $6M | $8M | $9M | $10M | $12M | $14M | $15M | $19M | $22M | |
| Intangibles | $355.5K | $378.4K | $407.2K | $438.2K | $469.2K | $500.0K | $530.6K | $553.2K | $382.5K | $411.7K | $441.0K | $466.5K | $389.6K | $412.6K | $435.6K | $458.6K | |
| Total Assets | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Accounts Payable | $684.4K | $293.5K | $270.7K | $247.2K | $263.4K | $272.2K | $273.5K | $273.8K | $322.2K | $336.8K | $317.3K | $367.0K | $344.4K | $353.4K | $3M | $327.8K | |
| Accrued Liabilities | · | · | $0 | $0 | $0 | $0 | $39.9K | $42.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $54.9K | |
| Current Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | $397.0K | |
| Total Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | · | |
| Common Stock | $6.5K | $3.1K | $3.1K | $2.6K | $2.6K | $2.6K | $1.7K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $14.1K | $1.4K | $14.1K | |
| Paid-in Capital | $82M | $78M | $78M | $74M | $74M | $74M | $71M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | |
| Retained Earnings | $-74M | $-72M | $-71M | $-69M | $-67M | $-66M | $-65M | $-63M | $-62M | $-60M | $-59M | $-57M | $-56M | $-55M | $-54M | $-48M | |
| Treasury Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $0 | $445.9K | $420.5K | $353.7K | $271.0K | $191.8K | · | · | $0 | · | |
| Stockholders' Equity | $9M | $6M | $8M | $6M | $7M | $8M | $6M | $7M | $8M | $9M | $10M | $12M | $14M | $15M | $16M | $22M | |
| Liabilities + Equity | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Shares Outstanding | 6,492,008 | 3,696,668 | 3,696,668 | 2,580,532 | 2,580,532 | 2,580,532 | 1,748,428 | 1,329,876 | 1,338,126 | 1,354,626 | 1,373,626 | 1,391,126 | 1,431,126 | 14,076,238 | 1,407,624 | 14,076,238 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $46.0K | · | $0 | $0 | $46.0K | · | · | · | · | · | $0 | |
| Stock-based Comp | $0 | $0 | $0 | $0 | $0 | $3.5K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | |
| Amort. of Intangibles | $22.9K | $28.9K | $30.9K | $31.1K | $30.7K | $30.6K | $22.6K | $29.3K | $29.3K | $29.3K | $25.5K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-985.6K | $-1M | $-896.9K | $-2M | $-1M | $-986.7K | $-4M | $-4M | $-873.3K | |
| Investing Cash Flow | $0 | $-175.0K | $-50.5K | $0 | $0 | $0 | $0 | $-200.0K | $0 | $7M | $933.9K | $2M | $-5M | $5M | $-5M | $-5M | |
| Stock Issued | $4M | $0 | · | · | $0 | $3M | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $10.0K | $0 | $25.4K | $66.7K | $82.8K | $79.2K | $191.8K | $0 | $0 | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-10.0K | · | · | · | $-82.8K | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $13.4K | $4M | $0 | $0 | $3M | $2M | $-25.4K | $-66.6K | $-82.8K | $-79.2K | $-191.8K | $0 | $0 | $0 | $12 | |
| Net Change in Cash | $3M | $-1M | · | · | $-1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 60.0% | · | · | 60.0% | · | · | 60.0% | · | · | · | 70.9% | |
| Operating Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| Net Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| Pretax Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| EBITDA Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| ROA | -18.4% | -19.0% | · | -19.4% | -16.3% | -18.2% | · | -10.7% | -14.1% | -8.4% | · | -8.3% | -5.9% | -8.4% | · | -7.7% | |
| ROE | -19.5% | -19.8% | · | -20.3% | -17.1% | -18.9% | · | -11.2% | -14.6% | -8.7% | · | -8.5% | -6.0% | -8.7% | · | -9.0% | |
| ROIC | -18.1% | -23.9% | · | -22.8% | -18.5% | -20.6% | · | · | -21.3% | -12.2% | · | -12.8% | -8.7% | -7.5% | · | -4.6% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.9 | 19.7 | · | 20.7 | 23.9 | 27.4 | · | 19.1 | 20.2 | 23.5 | · | 28.6 | 34.5 | 36.3 | · | 55.4 | |
| Quick Ratio | · | · | · | · | · | · | · | · | · | · | · | 10.7 | 10.0 | 23.4 | · | 42.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -22261.4 | · | · |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.5 | 0.0 | · | 0.2 | 0.0 | 0.0 | · | 2.0 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.33 | $1.65 | · | $2.17 | $2.65 | $3.12 | · | $4.93 | $5.69 | $6.81 | · | $8.69 | $9.59 | $1.05 | · | $1.57 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.36 | · | · | · | $-0.80 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | $3.24 | $2.79 | $0.68 | · | $1.21 | |
| EPS (TTM) | $-3.66 | $-3.73 | · | $-4.37 | $-4.64 | $-5.27 | · | · | · | · | · | $-4.02 | $-4.02 | $-4.02 | · | $-4.02 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.0K | $3.0K | · | $6.0K | $6.0K | $14.0K | · | $11.0K | $17.0K | $9.0K | · | $24.6K | $73.6K | $73.6K | · | $137.8K | |
| Net Income TTM | $-6M | $-6M | · | $-6M | $-6M | $-6M | · | $-5M | $-6M | $-5M | · | $-10M | $-9M | $-10M | · | $-8M | |
| Market Cap | $9M | $8M | · | $9M | $7M | $6M | · | $4M | $5M | $7M | · | $7M | $7M | $70M | · | $62M | |
| P/E | -0.4 | -0.6 | · | -0.8 | -0.6 | -0.4 | · | · | · | · | · | -1.2 | -1.2 | -1.2 | · | -1.1 | |
| P/S | 3137.8 | 2538.4 | · | 1432.2 | 1139.7 | 400.0 | · | 374.8 | 303.0 | 784.2 | · | 278.2 | 90.1 | 956.3 | · | 449.6 | |
| P/B | 1.1 | 1.2 | · | 1.5 | 1.0 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.7 | · | 2.8 | |
| P / Tangible Book | 1.1 | 1.3 | · | 1.7 | 1.1 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.9 | · | 2.9 | |
| P / Cash Flow | · | -5.8 | · | · | · | -3.5 | · | · | · | -7.9 | · | · | · | -18.3 | · | · | |
| Earnings Yield | -252.4% | -181.1% | · | -131.2% | -175.1% | -242.9% | · | · | · | · | · | -81.7% | -86.7% | -80.4% | · | -91.4% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K |
| Lucro líquido | $-6M | $-5M | $-5M | $-10M | $19M |
| EPS Diluído | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 |
Sem dados para esta demonstração
Ainda não há dados fundamentais suficientes para construir esta demonstração.
Sem dados para esta demonstração
Ainda não há dados fundamentais suficientes para construir esta demonstração.
Investidores institucionais (13F) 17 declarantes · $591K total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
17
Valor detido
$591K
Novas posições
6
Posições encerradas
3
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 6 (0 vs trimestre anterior) | 3 (-2 vs trimestre anterior) | 4 (+2 vs trimestre anterior) | 3 (+1 vs trimestre anterior) | +276K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Hudson Bay Capital Management LP | $195.997 | 135.170 | 33,14% | Ações |
| Anson Funds Management LP | $153.046 | 105.549 | 25,88% | Ações |
| ARMISTICE CAPITAL, LLC | $60.900 | 42.000 | 10,30% | Ações |
| VANGUARD GROUP INC | $50.701 | 25.868 | 8,57% | Ações |
| XTX Topco Ltd | $38.511 | 26.559 | 6,51% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $37.419 | 25.799 | 6,33% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.508 | 20.350 | 4,99% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $8.001 | 5.518 | 1,35% | Ações |
| Tower Research Capital LLC (TRC) | $7.037 | 4.853 | 1,19% | Ações |
| Global Retirement Partners, LLC | $5.971 | 4.118 | 1,01% | Ações |
| UBS Group AG | $2.989 | 2.061 | 0,51% | Ações |
| MORGAN STANLEY | $745 | 514 | 0,13% | Ações |
| HARBOUR INVESTMENTS, INC. | $325 | 224 | 0,05% | Ações |
| Bogart Wealth, LLC | $145 | 100 | 0,02% | Ações |
| BARCLAYS PLC | $78 | 54 | 0,01% | Ações |
| SBI Securities Co., Ltd. | $62 | 43 | 0,01% | Ações |
| Motiv8 Investments LLC | $0 | 1 | 0,00% | Ações |
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Creative Acquisition Corp., Timothy Warbington | 1 de Outubro de 2026 | 13,70% | Declaração inicial | Investimento passivo | SEC |
| Timothy Warbington, Creative Medical Health, Inc. ×5 declarações | 18 de Outubro de 2018 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 8 insiders · 3 diretores · 6 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Timothy Warbington | President & CEO | 28 de Junho de 2023 P | 12.209 | 0 | 0 | $0 |
| Donald Dickerson | CFO & Sr. VP | 9 de Fevereiro de 2022 A | · | 0 | 0 | $0 |
| Steven L White | President | 18 de Maio de 2016 S | 0 | 0 | 0 | $0 |
| Michael H. Finger | Conselheiro | 19 de Fevereiro de 2025 S | 351 | 0 | 0 | $0 |
| Thomas Ichim | Conselheiro | 22 de Julho de 2021 S | 4.529.522 | 0 | 0 | $0 |
| Amit Nilkanth Patel | Conselheiro | 15 de Julho de 2021 A | · | 0 | 0 | $0 |
| CREATIVE MEDICAL HEALTH INC. | Detentor de 10% | 8 de Janeiro de 2021 J | 113.474.233 | 0 | 0 | $0 |
| Timothy Herbst | Detentor de 10% | 2 de Dezembro de 2016 P | 11.346.667 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 1 ETF
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 20.350 SH | 19 de Agosto de 2026 | Diário |
CELZ Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 7 analistas
COMPRA
Alvo mediano
$20.00
+2013,3%
2 28,6%
Compra forte
4 57,1%
Compra
1 14,3%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
1 analistas · 2026-09-30Alvo médio $20.00 +2013,3%
Mín$20.00
Média$20.00
Máx$20.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| CELZ | · | -0.8 | -45.5% | · | · | · |
| BIAF | · | · | · | · | · | · |
| ACXP | $6M | -0.5 | · | · | -180.3% | · |
| SKYE | $25M | -0.5 | · | · | -175.6% | · |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | · |
| LNAI | $513M | -2.7 | · | · | -586.4% | · |
| ALZN | $5M | -0.4 | · | · | -598.1% | · |
| XBIO | · | -1.4 | 19.0% | · | · | · |
| CDIO | · | · | · | · | · | · |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 7, 2026